can i take tirzepatide and semaglutide at the same time Switching from to Switching from semaglutide to tirzepatide

Female participants (56% of the cohort) achieved an average of 25.3% weight loss at week 48

According to Eli Lilly's full year 2025 results, Mounjaro and Zepbound together posted combined sales of $36.5 billion, accounting for 56% of the company's total revenues of $65.2 billion, making tirzepatide the world's best-selling drug in 2025

GLP-1 drugs are effective because they delay the stomach from emptying, creating a feeling of fullness, thereby having an increased effect on weight loss

Food and Drug Administration (FDA) has approved semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA), to treat type 2 diabetes mellitus (T2DM) and obesity

This is particularly evident in specific cardiovascular conditions such as heart failure with preserved ejection fraction (HFpEF), for which effective treatments are scarce

Ready to see what's possible